...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

ACCORDING TO "GlobalData" https://www.globalda...

posted on Oct 26, 2023 08:02AM

October 26, 2023

Apabetalone by Resverlogix for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval

"Apabetalone is under clinical development by Resverlogix and currently in Phase I for Chronic Kidney Disease (Chronic Renal Failure). According to GlobalData, Phase I drugs for Chronic Kidney Disease (Chronic Renal Failure) have a 73% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how Apabetalone’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks."

https://www.pharmaceutical-technology.com/data-insights/apabetalone-resverlogix-chronic-kidney-disease-chronic-renal-failure-likelihood-of-approval/?cf-view